Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome
Introduction: Eltrombopag, a kind of thrombopoietin (TPO) receptor agonist, plays the role on the megakaryocyte to activate the platelet production and rapidly increase the number of circulating platelets in patients with primary immune thrombocytopenia (ITP). Eltrombopag provides an opportunity for...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publishing
2022-04-01
|
| Collection: | Science Progress |
| Accès en ligne: | https://doi.org/10.1177/00368504221102786 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|